Hangzhou Tigermed Consulting (03347): As of June 16, a total of 17.783 million shares of A shares have been repurchased.
Tage Pharmaceuticals (03347) announced that as of June 16, 2026, the company repurchased 17.783 million shares through its share repurchase special securities account in the form of centralized bidding trading, accounting for 2.0654% of the company's current total share capital and 2.4100% of the company's current A-share total share capital. The highest transaction price was 39.96 yuan/share, the lowest transaction price was 38.22 yuan/share, and the total transaction amount was 698.9 million yuan (excluding transaction costs). This repurchase is in compliance with the company's share repurchase plan and relevant laws and regulations.
Hangzhou Tigermed Consulting (03347) announced that as of June 16, 2026, the company has repurchased a total of 17.783 million shares through the stock repurchase special securities account in a centralized bidding trading manner, representing 2.0654% of the company's total share capital and 2.4100% of the company's current A-share total share capital. The highest transaction price was 39.96 yuan per share, the lowest transaction price was 38.22 yuan per share, and the total transaction amount was 698.9 million yuan (excluding transaction fees). This repurchase meets the requirements of the company's share repurchase plan and relevant laws and regulations.
Related Articles
.png)
InnoCare Pharma (688428.SH) awarded 8 million restricted shares to 100 incentive recipients.
Hong Kong's public offering received a subscription of 5,144.97 times, raising approximately HK$913 million in net proceeds from the global offering.
TIANGONG INT'L (00826): Zhu Zhonghua has been elected as an executive director.
InnoCare Pharma (688428.SH) awarded 8 million restricted shares to 100 incentive recipients.
Hong Kong's public offering received a subscription of 5,144.97 times, raising approximately HK$913 million in net proceeds from the global offering.
TIANGONG INT'L (00826): Zhu Zhonghua has been elected as an executive director.
RECOMMEND
